Medical Program: Clinical Implications of Heart Failure Trials Presented at the ACC.20/WCC Virtual Late-Breaker Session

Clinical Implications of Heart Failure Trials Presented at the ACC.20/WCC Virtual Late-Breaker Session

Clinical Implications of Heart Failure Trials Presented at the ACC.20/WCC Virtual Late-Breaker Session
RestartResume

Do you know the current pillars of heart failure therapy? Discover the highlights from the VICTORIA, DAPA-HF, PIONEER-HF, and PARADIGM-HF trials presented at ACC.20/WCC Virtual.

  • Overview

    Tune in as Drs. Javed Butler (University of Mississippi) and John McMurray (University of Glasgow) discuss highlights of the heart failure clinical trials VICTORIA, DAPA-HF, PIONEER-HF, and PARADIGM-HF, which were presented at the ACC.20/WCC Virtual late-breaker session. These trials increase available medical options and the complexity of heart failure management, so join our leading experts for guidance on incorporating these data into your clinical practice.

Facebook Comments

Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free